Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Merck & Co. files marketing authorization application with EMEA for vorinostat

Nov. 27, 2007

European Commission approves Wyeth Pharmaceuticals' Torisel for renal cell carcinoma

Nov. 27, 2007

Selective and multitargeted B-Raf inhibitors described at Deciphera

Nov. 27, 2007

Bristol-Myers Squibb and Pierre Fabre terminate license agreement for vinflunine

Nov. 26, 2007

FDA approves Bionomics' IND application for anticancer compound BNC-105

Nov. 26, 2007

Recent patents divulge new therapeutic agents for cancer

Nov. 26, 2007

Hana initiates phase II clinical trial of Marqibo for metastatic malignant uveal melanoma

Nov. 23, 2007

Merck & Co. suspends enrollment in clinical trials of kinase inhibitor MK-0457

Nov. 23, 2007

Antisoma provides update on clinical development of its anticancer compounds

Nov. 22, 2007

Preclinical profile of novel oncolytic measles virus

Nov. 22, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.